These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11575711)

  • 1. S-8921 (Shionogi).
    Booker ML
    Curr Opin Investig Drugs; 2001 Mar; 2(3):393-5. PubMed ID: 11575711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption.
    Ichihashi T; Izawa M; Miyata K; Mizui T; Hirano K; Takagishi Y
    J Pharmacol Exp Ther; 1998 Jan; 284(1):43-50. PubMed ID: 9435159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action.
    Sakamoto S; Kusuhara H; Miyata K; Shimaoka H; Kanazu T; Matsuo Y; Nomura K; Okamura N; Hara S; Horie K; Baba T; Sugiyama Y
    J Pharmacol Exp Ther; 2007 Aug; 322(2):610-8. PubMed ID: 17470645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytoplasmic proteins in hepatic bile acid transport.
    Stolz A; Takikawa H; Ookhtens M; Kaplowitz N
    Annu Rev Physiol; 1989; 51():161-76. PubMed ID: 2653179
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol absorption inhibitors in development as potential therapeutics.
    Kajinami K; Takekoshi N
    Expert Opin Investig Drugs; 2002 Jun; 11(6):831-5. PubMed ID: 12036426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug evaluation: The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia.
    Burnett JR
    IDrugs; 2006 Jul; 9(7):495-9. PubMed ID: 16821163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology, diagnosis, and treatment of cholelithiasis--with special reference to hepato-intestinal circulation of bile acid].
    Makino I
    Nihon Naika Gakkai Zasshi; 2001 Mar; 90(3):428-33. PubMed ID: 11307530
    [No Abstract]   [Full Text] [Related]  

  • 9. Tresperimus (Laboratoires Fournier).
    Elices MJ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):372-4. PubMed ID: 11575707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid transport.
    Bahar RJ; Stolz A
    Gastroenterol Clin North Am; 1999 Mar; 28(1):27-58. PubMed ID: 10198777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94.
    Root C; Smith CD; Sundseth SS; Pink HM; Wilson JG; Lewis MC
    J Lipid Res; 2002 Aug; 43(8):1320-30. PubMed ID: 12177176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ileal bile acid transport: desirability of measuring transport function as well as transporter activity.
    Hofmann AF
    Hepatology; 1999 Apr; 29(4):1335-7. PubMed ID: 10336336
    [No Abstract]   [Full Text] [Related]  

  • 13. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CETi-1. AVANT.
    Komori T
    Curr Opin Investig Drugs; 2004 Mar; 5(3):334-8. PubMed ID: 15083601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidaemic agents.
    Howe R
    Adv Drug Res; 1974; 9():7-39. PubMed ID: 4618980
    [No Abstract]   [Full Text] [Related]  

  • 16. A new era in bile acid transport pathophysiology.
    Shneider BL
    J Pediatr Gastroenterol Nutr; 1998 Feb; 26(2):236-7. PubMed ID: 9481648
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
    Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
    Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopic transplantation of intestinal mucosal organoids in rodents.
    Avansino JR; Chen DC; Hoagland VD; Woolman JD; Stelzner M
    Surgery; 2006 Sep; 140(3):423-34. PubMed ID: 16934605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.
    Hofmann AF; Hagey LR
    Cell Mol Life Sci; 2008 Aug; 65(16):2461-83. PubMed ID: 18488143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation.
    Brinton EA
    Diabetes Obes Metab; 2008 Nov; 10(11):1004-11. PubMed ID: 18494807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.